Preclinical examination of first and second generation photosensitizers used in photodynamic therapy.
about
Are porphyrin mixtures favorable photodynamic anticancer drugs? A model study with combinatorial libraries of tetraphenylporphyrins.Transient absorption changes in vivo during photodynamic therapy with pulsed-laser light.Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC.The depth of porphyrin in a membrane and the membrane's physical properties affect the photosensitizing efficiency.Photodynamic effects in vitro in fresh gynecologic tumors analyzed with a bioluminescence method.Therapeutic effect of diode laser photodynamic therapy with ICG dye in ARMD: a case report.Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.Photodynamic therapy with fullerenes.Dynamics of photoinduced cell plasma membrane injuryEffect of Photofrin-mediated photocytotoxicity on a panel of human pancreatic cancer cells.Current and emerging treatment options for uveal melanoma.Fluorescence and photodynamic effects of bacteriochlorin a observed in vivo in 'sandwich' observation chambers.A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin.Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model.A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma modelTreatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer modelA regulatory role for porphobilinogen deaminase (PBGD) in delta-aminolaevulinic acid (delta-ALA)-induced photosensitization?Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates.Photodynamic therapy results in induction of WAF1/CIP1/P21 leading to cell cycle arrest and apoptosisDelta-aminolaevulinic acid-induced photodynamic therapy inhibits protoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitro.Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression.Lipid nanoemulsions and liposomes improve photodynamic treatment efficacy and tolerance in CAL-33 tumor bearing nude micePhotodynamic therapy: a review and its prospective role in the management of oral potentially malignant disorders.Development and characterization of bio-derived polyhydroxyalkanoate nanoparticles as a delivery system for hydrophobic photodynamic therapy agents.Photoactivatable prodrugs of highly potent duocarmycin analogues for a selective cancer therapy.Determination of time-dependent protoporphyrin IX concentration for photodynamic therapy dosimetry in a mice colon tumor model using fluorescence spectroscopy.Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4.Response of Photofrin-sensitised mesothelioma xenografts to photodynamic therapy with 514 nm light.Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis. Antisense Bcl-2 oligonucleotide sensitizes RIF 1 cells to photodynamic therapy apoptosis.Cytologic effects of photodynamic therapy in body fluids.Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy.Interstitial photodynamic therapy with the second-generation photosensitizer bacteriochlorin a in a rat model for liver metastases.Tumour localisation kinetics of photofrin and three synthetic porphyrinoids in an amelanotic melanoma of the hamster.Photogeneration of singlet oxygen (1O2) and free radicals (Sen*-, O2*-) by tetra-brominated hypocrellin B derivative.Developing the next generation of graphene-based platforms for cancer therapeutics: The potential role of reactive oxygen species.Tin ethyl etiopurpurin significantly inhibits vascular smooth muscle cell proliferation in vivo.Porphyrin photosensitizers in photodynamic therapy and its applications.Is Antimicrobial Photodynamic Therapy Effective as an Adjunct to Scaling and Root Planing in Patients with Chronic Periodontitis? A Systematic Review.ESR studies of a series of phthalocyanines. Mechanism of phototoxicity. Comparative quantitation of O2-. using ESR spin-trapping and cytochrome c reduction techniques.Advanced smart-photosensitizers for more effective cancer treatment.
P2860
Q30629382-6E37083B-AA50-4DD0-BB29-1A67ECCE286CQ30735976-8A12DA7B-A623-4BF5-87E4-D2DD052C1EADQ30818425-EEC8D173-B87E-4405-BBF8-C4564ACD1306Q30828403-06AAFDAF-9F76-4242-A302-7164D064A20BQ31271163-1493BE45-AD76-4AEA-88DA-988B88ED0E0CQ33282850-C86D3864-01E7-4ABB-B6EE-F96BBE208D11Q33939514-849EDD25-BF32-4ABE-9B78-45CFE4E0C5B2Q34104388-6BB4D4A7-1CBD-427E-B9E8-9BA447590D39Q34129545-A9B0E1A3-51DF-4372-B8C4-4866062C7F9BQ34252361-DD821B20-9F74-4D17-ACC6-1097B8B687B3Q34655878-A4041807-0C37-4A02-8322-12989501EB89Q35976785-98975A99-8D2C-4B09-8423-2825747104D1Q36079416-9F33A161-5210-4667-B94C-6DC485E69075Q36079579-54DF2F40-7428-4F7A-BF14-62A46B9070CCQ36138692-07131974-1307-48F5-9CE2-0B3A9B1F50EAQ36138950-5C09F8B2-B79E-41D5-A03E-EBD2A4500B47Q36294855-6D6AEA9D-E5C9-4A83-B8FB-F3E72834719CQ36419971-998D74B8-7814-48A9-95E0-BCAE43A5428BQ36502053-2AAC6700-CFF8-49B0-ADED-CDF07506158AQ36620285-25B751B3-7663-4870-AEE2-71C7C2CF0168Q36861438-A1D7A139-C0D3-448A-AAB8-84ADAE4D1D95Q37307865-BCA607F6-A541-4F2A-BFBE-5E80452F9AFAQ38147577-C64202FB-ED19-4BE8-9CC9-15FCE6C0A12EQ38808333-6AC339CA-8081-4206-A526-72FE1E077AF2Q39229406-01953373-90EA-4C65-AC98-B0AB6AC59546Q39622246-0AC7C5DE-0B5F-462D-BAA1-5242BF344BFFQ40020538-6B41A566-CCA5-491E-9C3D-E3AC06E3D8CFQ40024960-4A1DB448-CBA2-4167-89CE-5BE4206D4885Q40817417-C328037F-87FC-4413-9DC6-DC1DFD284928Q41048015-C2D07804-2870-4A86-A2DE-FAB67649C2C1Q41177935-1ED0441F-313E-4835-8AD8-DF53B921E8F7Q42061393-3034055E-0568-4CEA-BB0A-0F0AA99B76B2Q42389821-5014E94A-7721-4F03-ABD4-69CE690EDBC4Q43866481-9C0E7429-2EBA-47CA-93F1-2AEFF63E6977Q46249420-CDF06B2C-82D4-4912-842F-7B05C4230C2AQ46759074-FF37914D-F1AF-4304-8A2B-6D6C9A2039D9Q47096935-14C095CC-CFB9-44DD-95AC-3AC941BF23C5Q47127619-24F8D15B-E6EA-4FC1-B70C-49A88D342B53Q47693098-F30CD710-0CEC-4DF4-9D0C-01A81EEC3C11Q47795195-168AF1C9-2C6B-46F0-87A5-76D3D167BA9E
P2860
Preclinical examination of first and second generation photosensitizers used in photodynamic therapy.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Preclinical examination of fir ...... used in photodynamic therapy.
@en
type
label
Preclinical examination of fir ...... used in photodynamic therapy.
@en
prefLabel
Preclinical examination of fir ...... used in photodynamic therapy.
@en
P2860
P1476
Preclinical examination of fir ...... used in photodynamic therapy.
@en
P2093
P2860
P304
P356
10.1111/J.1751-1097.1991.TB02133.X
P577
1991-12-01T00:00:00Z